Rakovina Therapeutics

corporate Profile

Investor Information

EXCHANGE

SYMBOL

TRANSFER AGENT

AUDITORS

LEGAL COUNSEL

CORPORATE HEADQUARTERS

FOUNDED

TSX Venture Exchange (TSXV)

RKV 

Computershare Investor Services Inc.

Davidson & Company LLP

Blake, Cassels & Graydon LLP

Suite 2201 – 8 Smithe Mews Vancouver, British Columbia V6B OA5

September 25, 2020

EXCHANGE

TSX Venture Exchange (TSXV)

SYMBOL

RKV

TRANSFER AGENT

Computershare Investor Services Inc.

AUDITORS

Davidson & Company LLP

LEGAL COUNSEL

Blake, Cassels & Graydon LLP

CORPORATE HEADQUARTERS

Suite 2201 – 8 Smithe Mews Vancouver, British Columbia V6B OA5

FOUNDED

September 25, 2020

Market Summary

The above stock summary is delayed, and it does not reflect real time stock prices. Rakovina Therapeutics Inc does not make, and expressly disclaims, any warranty, express or implied, statutory or otherwise, as to the site you are about to link to, including but not limited to, any content of the site or sites your are linking to.

Corporate Presentation

Read our corporate presentation here.

Sedar Documents

View the sedar documents here.

Investor Contact

Company Contact
[email protected]

Investor Relations Contact
[email protected]

Media Contact
[email protected]

Subscribe